抗凝治疗下的黑洞征象:华法林与直接口服抗凝剂的回顾性比较。

Hirotaka Sato, Manabu Kinoshita, Takuma Takano, Takahiro Sanada, Seiya Fujikawa, Masahiro Toda, Kiyoshi Choji, Teruo Kimura
{"title":"抗凝治疗下的黑洞征象:华法林与直接口服抗凝剂的回顾性比较。","authors":"Hirotaka Sato, Manabu Kinoshita, Takuma Takano, Takahiro Sanada, Seiya Fujikawa, Masahiro Toda, Kiyoshi Choji, Teruo Kimura","doi":"10.3174/ajnr.A8528","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Direct oral anticoagulants (DOAC) have rapidly replaced warfarin. Intracerebral hemorrhage (ICH) is known to be one of the most severe side effects of anticoagulant drugs. The black hole (BH) sign is reportedly a valid radiological sign for predicting hematoma expansion in acute ICH. Here, we hypothesized that the frequency of BH signs might differ between warfarin and DOAC treatment, and critically evaluated the clinical value of the BH sign in acute ICH under warfarin versus DOAC therapy.</p><p><strong>Materials and methods: </strong>Patients with acute ICH under anticoagulant therapy were enrolled. Hematoma volumes were measured by ABC/2. Radiologists blinded to the clinical information determined the presence or absence of the BH sign on CT images. This study defined a more than 12.5 ml increase in hematoma volume as cases with \"expanded hematoma\".</p><p><strong>Results: </strong>We analyzed 111 acute ICH patients under anticoagulant therapy. Among them, 21 patients were treated with antagonists in this cohort. Multivariate logistic regression analysis revealed that the presence of ventricular perforation (<i>p</i>=0.02; adjusted odds ratio (OR): 3.51, 95% confidence interval (CI): 1.32 - 10.2) and the BH sign (<i>p</i><0.01; adjusted OR: 4.86, 95% CI: 1.73 - 14.3) were significantly different between expanded and non-expanded hematoma cases. Comparison of hematoma volume and the presence of the BH sign between warfarin and DOAC cases indicated significant differences in maximum hematoma volume (<i>p</i>=0.03) and presence of the BH sign (<i>p</i><0.01). The increase in hematoma volume was significantly greater when the BH sign was present under warfarin therapy (<i>p</i>=0.05). In contrast, the increase in hematoma volume did not differ between cases with and without the BH sign in patients under DOAC therapy (<i>p</i>=0.14) CONCLUSIONS: The BH sign is a useful radiological signature to predict the expansion of acute ICH under anticoagulant therapy. ICH under warfarin tended to present the BH sign more frequently than that under DOAC. The results also showed that the BH sign is more reliable under warfarin than under DOAC therapy in ICH patients.</p><p><strong>Abbreviations: </strong>AF = atrial fibrillation; BH = black hole; DOAC = direct oral anticoagulants; HU = Hounsfield Unit; ICH= intracerebral hemorrhage.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Black hole sign under anticoagulant therapy: A retrospective comparison of warfarin and direct oral anticoagulants.\",\"authors\":\"Hirotaka Sato, Manabu Kinoshita, Takuma Takano, Takahiro Sanada, Seiya Fujikawa, Masahiro Toda, Kiyoshi Choji, Teruo Kimura\",\"doi\":\"10.3174/ajnr.A8528\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>Direct oral anticoagulants (DOAC) have rapidly replaced warfarin. Intracerebral hemorrhage (ICH) is known to be one of the most severe side effects of anticoagulant drugs. The black hole (BH) sign is reportedly a valid radiological sign for predicting hematoma expansion in acute ICH. Here, we hypothesized that the frequency of BH signs might differ between warfarin and DOAC treatment, and critically evaluated the clinical value of the BH sign in acute ICH under warfarin versus DOAC therapy.</p><p><strong>Materials and methods: </strong>Patients with acute ICH under anticoagulant therapy were enrolled. Hematoma volumes were measured by ABC/2. Radiologists blinded to the clinical information determined the presence or absence of the BH sign on CT images. This study defined a more than 12.5 ml increase in hematoma volume as cases with \\\"expanded hematoma\\\".</p><p><strong>Results: </strong>We analyzed 111 acute ICH patients under anticoagulant therapy. Among them, 21 patients were treated with antagonists in this cohort. Multivariate logistic regression analysis revealed that the presence of ventricular perforation (<i>p</i>=0.02; adjusted odds ratio (OR): 3.51, 95% confidence interval (CI): 1.32 - 10.2) and the BH sign (<i>p</i><0.01; adjusted OR: 4.86, 95% CI: 1.73 - 14.3) were significantly different between expanded and non-expanded hematoma cases. Comparison of hematoma volume and the presence of the BH sign between warfarin and DOAC cases indicated significant differences in maximum hematoma volume (<i>p</i>=0.03) and presence of the BH sign (<i>p</i><0.01). The increase in hematoma volume was significantly greater when the BH sign was present under warfarin therapy (<i>p</i>=0.05). In contrast, the increase in hematoma volume did not differ between cases with and without the BH sign in patients under DOAC therapy (<i>p</i>=0.14) CONCLUSIONS: The BH sign is a useful radiological signature to predict the expansion of acute ICH under anticoagulant therapy. ICH under warfarin tended to present the BH sign more frequently than that under DOAC. The results also showed that the BH sign is more reliable under warfarin than under DOAC therapy in ICH patients.</p><p><strong>Abbreviations: </strong>AF = atrial fibrillation; BH = black hole; DOAC = direct oral anticoagulants; HU = Hounsfield Unit; ICH= intracerebral hemorrhage.</p>\",\"PeriodicalId\":93863,\"journal\":{\"name\":\"AJNR. American journal of neuroradiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AJNR. American journal of neuroradiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3174/ajnr.A8528\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A8528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:直接口服抗凝药(DOAC)已迅速取代华法林。众所周知,脑出血(ICH)是抗凝药物最严重的副作用之一。据报道,黑洞(BH)征是预测急性 ICH 血肿扩大的有效放射学征象。在此,我们假设华法林和 DOAC 治疗中出现 BH 征的频率可能不同,并严格评估了 BH 征在华法林和 DOAC 治疗下急性 ICH 中的临床价值:纳入抗凝治疗的急性 ICH 患者。用 ABC/2 测量血肿体积。对临床信息保密的放射科医生确定 CT 图像上是否存在 BH 征。本研究将血肿体积增加超过 12.5 毫升定义为 "血肿扩大 "病例:我们分析了 111 例接受抗凝治疗的急性 ICH 患者。结果:我们分析了 111 例接受抗凝治疗的急性 ICH 患者,其中 21 例患者接受了拮抗剂治疗。多变量逻辑回归分析显示,存在心室穿孔(P=0.02;调整后的几率比(OR)为 3.51,95% 置信区间为 0.01)的患者中,血肿扩大(P=0.01;调整后的几率比(OR)为 0.01)的比例最高:3.51,95% 置信区间(CI):1.32 - 10.2)、BH 征(pp=0.03)和出现 BH 征(pp=0.05)。相比之下,在接受 DOAC 治疗的患者中,有 BH 征和无 BH 征的病例血肿体积增加没有差异(P=0.14):BH 征是预测抗凝治疗下急性 ICH 扩大的有效放射学特征。华法林治疗下的 ICH 比 DOAC 治疗下的 ICH 更常出现 BH 征。结果还显示,在 ICH 患者中,华法林比 DOAC 治疗下的 BH 征更可靠:缩写:AF= 心房颤动;BH= 黑洞;DOAC= 直接口服抗凝药;HU= 霍斯菲尔德单位;ICH= 脑内出血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Black hole sign under anticoagulant therapy: A retrospective comparison of warfarin and direct oral anticoagulants.

Background and purpose: Direct oral anticoagulants (DOAC) have rapidly replaced warfarin. Intracerebral hemorrhage (ICH) is known to be one of the most severe side effects of anticoagulant drugs. The black hole (BH) sign is reportedly a valid radiological sign for predicting hematoma expansion in acute ICH. Here, we hypothesized that the frequency of BH signs might differ between warfarin and DOAC treatment, and critically evaluated the clinical value of the BH sign in acute ICH under warfarin versus DOAC therapy.

Materials and methods: Patients with acute ICH under anticoagulant therapy were enrolled. Hematoma volumes were measured by ABC/2. Radiologists blinded to the clinical information determined the presence or absence of the BH sign on CT images. This study defined a more than 12.5 ml increase in hematoma volume as cases with "expanded hematoma".

Results: We analyzed 111 acute ICH patients under anticoagulant therapy. Among them, 21 patients were treated with antagonists in this cohort. Multivariate logistic regression analysis revealed that the presence of ventricular perforation (p=0.02; adjusted odds ratio (OR): 3.51, 95% confidence interval (CI): 1.32 - 10.2) and the BH sign (p<0.01; adjusted OR: 4.86, 95% CI: 1.73 - 14.3) were significantly different between expanded and non-expanded hematoma cases. Comparison of hematoma volume and the presence of the BH sign between warfarin and DOAC cases indicated significant differences in maximum hematoma volume (p=0.03) and presence of the BH sign (p<0.01). The increase in hematoma volume was significantly greater when the BH sign was present under warfarin therapy (p=0.05). In contrast, the increase in hematoma volume did not differ between cases with and without the BH sign in patients under DOAC therapy (p=0.14) CONCLUSIONS: The BH sign is a useful radiological signature to predict the expansion of acute ICH under anticoagulant therapy. ICH under warfarin tended to present the BH sign more frequently than that under DOAC. The results also showed that the BH sign is more reliable under warfarin than under DOAC therapy in ICH patients.

Abbreviations: AF = atrial fibrillation; BH = black hole; DOAC = direct oral anticoagulants; HU = Hounsfield Unit; ICH= intracerebral hemorrhage.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信